Loading clinical trials...
Loading clinical trials...
A Pilot Study to Assess Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
Conditions
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
January 3, 2024
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
March 12, 2026
NCT03087253
NCT06679270
NCT03553420
NCT06484868
NCT02262832
NCT03936829
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions